According to Scribe Therapeutics's latest financial reports the company's current earnings are $51.17 Million USD. In 2025 the company made an earning of -$21.22 Million USD, an increase over its 2024 earnings that were of -$35.18 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.